Showing posts with label ASEAN. Show all posts
Showing posts with label ASEAN. Show all posts

Wednesday, April 17, 2013

Enter ASEAN

The Far East has long captivated Western societies with philosophies and healing practices. Throughout history, trade was brisk along the spice routes, themselves considered a gateway of commerce, bringing treasures and wisdoms to Westerners who clamored for them and could afford them.

In the modern world, it seems, many of the Far Eastern peoples have become interested in emulating Western practices and consuming our products. And although many hold fast to their traditional medicinal systems (such as traditional Chinese medicine [TCM] in and around China), Western dietary supplements have made tremendous inroads, cultivating growing followings.

According to Reuel A. Igaña, an executive at FUDynamics International Inc., San Juan, Philippines, the total Asia Pacific nutritional supplement market in 2010 (excluding Japan, PROC and Australasia) was estimated to be worth US$11billion, and is expected to grow exponentially and quickly to US$28.5 billion by 2016. The southeast Asian health supplements industry is estimated to be worth more than US$2.5 to 3 billion, and the market is expected to grow at an annual rate of 10 percent each year.

"Similar to Americans, the affluent Asian consumers from Singapore, Malaysia, Thailand, Indonesia and Philippines are discerning consumers who appreciate products that are efficacious, safe and of premium quality," Igaña observed.

Interestingly, Igaña noted U.S.-made dietary supplement products are "perceived to be of good quality, with supporting testimonials and clinical data to substantiate claims. While the market is highly competitive and somewhat saturated, the best prospects include innovative supplements with scientifically proven benefits and focused on preventative care," he said.

The dynamics spurring the growth and strength of the Asian market again seem to mirror those in the United States: rising affluence, higher income and standard of living; the growing pursuit of healthier lifestyles, longer life expectancies; the sharply increased empowerment of women; and growth of young adults who consider themselves "trendy" as opposed traditional.

For more of the article, http://www.naturalproductsinsider.com/articles/2013/04/enter-asean.aspx





Sign up for DIA's Global SmartBrief: Break through the information clutter with FREE, twice-weekly email publication that gives quick, easy-to-read summaries of articles relevant to you. Get the latest news in drug development innovations worldwide wherever you are on your laptop or smart phone with SmartBrief’s wireless compatibility.

Wednesday, December 12, 2012

Be a Part of Asia’s Most Innovative Regulatory Conference!


Asia Regulatory
Conference 2013
News & PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
 
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
 
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
 
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Are you a Representative of Health Authorities, a Regulatory Affairs professional, or a professional involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia? If so, then this conference is for you.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.
SAVE THE DATE: 5th Annual Meeting DIA CHINA
2013 | May 12-15, 2013 | Beijing, China

Wednesday, November 28, 2012

Regulatory Convergence and Cooperation to Improve Access and Quality -Singapore


Asia Regulatory
Conference 2013
News & PublicationsMeetings
& TrainingsSpeaking & PublishingNetworking & CommunitiesExhibiting AdvertisingCareer Center
Regulatory Conference Program Now Available!
To kick off 2013, the Asia Regulatory Conference is bringing together global regulatory professionals to share past experiences and new practices. Don’t miss this exciting event to interact with regulatory and other professionals!
OVERVIEW
Join health authority representatives and industry professionals from Asian and ICH member
countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.
OBJECTIVES
This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines.
This conference will provide a forum to:
• Facilitate discussion on common issues in the regulatory and technical areas in Asia
• Encourage greater convergence of regulatory requirements in Asia
• Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Day One – Research and Development
Day Two – Good Regulatory Practices
Day Three – 21st century Global Regulatory Challenges
Program
committee
chairs
Arun Mishra
Director
Global Regulatory Affairs
GlaxoSmithKline, UK
John C.W. Lim
Chief Executive Officer
Health Sciences Authority,
Singapore 
Who Should Attend
Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
  • Ministries of Health and Medicines
  • Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development
  • Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)
To know more contact Ellen.Diegel@diahome.org.
SAVE THE DATE: 5th Annual Meeting DIA CHINA
2013 | May 12-15, 2013 | Beijing, China

Tuesday, November 6, 2012

Asia Regulatory Conference 2013 - Jan 28-30, Singapore

Asia Regulatory Conference 2013

Jan 28 2013 7:00AM - Jan 30 2013 5:00PM | Raffles City Convention Centre 252 North Bridge Road Singapore 179103 Singapore

Overview

Join health authority representatives and industry professionals from Asian and ICH member countries as they continue to discuss regulatory aspects of ICH, APEC and ASEAN convergence initiatives, good regulatory practices, quality and GMP, global drug development, and pharmacovigilance.

Who Should Attend

Representatives of Health Authorities, Regulatory Affairs professionals, and other professionals involved in or interested in the aspects surrounding registration of medicinal products and regulatory convergence initiatives in Asia.
In particular professionals involved in:
  • Ministries of Health and Medicines Regulatory Authorities
  • Regulatory Affairs
  • Clinical Research and Development Safety and Pharmacovigilance
  • Clinical Trial and Project Management
  • CMC/Quality (Quality, Manufacturing and Controls)

Learning Objectives

This three-day conference offers a unique opportunity for key stakeholders from health authorities, local and multinational pharmaceutical companies, and clinical research to meet and exchange views, discuss topics of interest and identify focus areas for ongoing efforts to increase patient access to new and improved medicines. This conference will provide a forum to:
  • Facilitate discussion on common issues in the regulatory and technical areas in Asia
  • Encourage greater convergence of regulatory requirements in Asia
  • Strengthen cooperation between Asian regulatory authorities and pharmaceutical industry
Conference speakers will include top-level regulatory authorities from several Asian countries as well as leading experts in the ICH process. In addition, speakers will include representatives of WHO, various regulatory agencies from other regions and the multinational and local pharmaceutical industry.

<< link to program >>